Health Condition 1: null- Cancer of Cervix
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
None listed
Eligibility
Inclusion criteria
Inclusion criteria: Histologically confirmed FIGO stage Ib2-IVa squamous, adeno or adenosquamous carcinoma of the cervix. Received Neo-adjuvant chemotherapy (NACT) followed by Chemo-radiotherapy (CRT) or Radiotherapy (RT). Minimum follow-up of 2 years after completion of Chemo-radiotherapy (CRT) / Radiotherapy (RT).
Exclusion criteria
Exclusion criteria: Incomplete definitive treatment. Not received Chemo-radiotherapy (CRT) / Radiotherapy (RT).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate Neoadjuvant chemortherapy(NACT)followed by radical chemoradiotherapy(CRT) or radiotherapy(RT) in locally advanced cervical cancer in terms of Response rates, Compliance of NACT followed by Radical Chemoradiotherapy/Radiotherapy & Disease free & overall survivals & factors affecting the outcome.Timepoint: 2 Years | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate Neoadjuvant chemortherapy(NACT)followed by radical chemoradiotherapy(CRT) or radiotherapy(RT) in locally advanced cervical cancer in terms of Response rates, Compliance of NACT followed by Radical Chemoradiotherapy/Radiotherapy & Disease free & overall survivals & factors affecting the outcome.Timepoint: 2 Years | — |
Countries
India
Contacts
Public ContactDr Umesh Mahantshetty
Tata Memorial Hospital.
Outcome results
None listed